Screening and Early Detection Committee

The IASLC Screening and Early Detection Committee works to advance screening and early detection programs through education and research across the globe. They are a multidisciplinary group composed of leaders from medical oncology, nursing, radiology, thoracic surgery, pulmonary medicine, epidemiology, basic science, and advocacy organizations. They boast representation from North America, Europe, Asia, and South America. Overall, the IASLC Screening and Early Detection Committee plays a vital role in shaping the global landscape of lung cancer screening and early detection by leveraging the expertise of its diverse members and driving meaningful advancements in the field.
Screening and Early Detection Committee

Overview

Committee Responsibilities: 

  1. Research: They collaborate to identify and support research initiatives focused on improving screening methods, early detection technologies, and risk assessment tools, contributing to the development of evidence-based guidelines. 
  2. Education: The committee designs and facilitates educational programs, workshops, webinars, and conferences to disseminate the latest advancements and best practices in lung cancer screening and early detection to medical professionals globally through the IASLC learning management system. 
  3. Multidisciplinary Collaboration: Committee members, representing diverse medical disciplines, collaborate to integrate their expertise and perspectives, fostering a holistic approach to lung cancer screening and early detection strategies. 
  4. Global Outreach: The committee engages with healthcare organizations, advocacy groups, and governments around the world to promote awareness, collaboration, and adoption of effective screening and early detection programs. 
  5. Data Sharing and Analysis: They work to facilitate data sharing and analysis among institutions, promoting a data-driven approach to refining screening protocols, risk assessment models, and treatment pathways. 
  6. Advocacy: The committee advocates for increased public awareness of the importance of early detection in lung cancer outcomes, engaging with patient advocacy groups, industry and policymakers to promote policy and funding support for national screening programs. 
  7. Publication and Dissemination: They contribute to scientific literature through research publications, review articles, and position papers, disseminating their findings and recommendations to the broader medical community through publication in the Journal of Thoracic Oncology (JTO). 

Committee projects

I-ELCAP/IASLC Teaching Files

This project aims to develop the largest global web-based teaching file designed to educate users on the diverse radiological presentations of early lung cancer and related pulmonary findings. The teaching file will feature a comprehensive collection of searchable standardized cases, along with integrated learning modules and self-assessment tools. This initiative seeks to enhance accessibility to lung cancer screening and improve the management of pulmonary nodules.

Air Pollution and Lung Cancer Webinar

Air pollution is increasingly becoming a health concern, and this webinar aims to detail the relationship between air pollution and lung cancer. The project will focus on disseminating information about the risks of lung cancer associated with air pollution, the actions that can be taken to help patients with lung cancer, and how the healthcare sector can provide remediation.

Chair of Committee

Annette McWilliams
Annette McWilliams
2023 to present

2023-2025 Roster

Annette McWilliams
Australia
University of Western Australia Medical School
Committee Chair
Stephen Lam
Canada
British Columbia Cancer Agency
Past Chair
Rudolf M. Huber
Germany
University of Munich
Deputy Chair
Antoni Rosell
Spain
Hospital University Germans Trias
Board Liaison
Keelan Zius
United States
International Association for the Study of Lung Cancer
Staff Liaison
Melinda Aldrich
United States
Vanderbilt University Medical Center
Committee Member
Haval Balata
United Kingdom
University Hopsitals of South Manchester
Committee Member
David Baldwin
United Kingdom
Nottingham University Hospitals
Committee Member
Andrea Borondy Kitts
United States
Committee Member
Milena Cavic
Serbia
Institute for Oncology and Radiology of Serbia
Committee Member
John Field
United Kingdom
University of Liverpool
Committee Member
Kwun Fong
Australia
The Prince Charles Hospital / University of Queensland Thoracic Research Center
Committee Member
Anne Fraser
New Zealand
Auckland District Health Board
Committee Member
Claudia Henschke
United States
Mt. Sinai School of Medicine
Committee Member
Marjolein Heuvelmans
Netherlands
University Medical Center Groningen
Committee Member
Long Jiang
China
Shanghai Chest Hospital
Committee Member
Ella Kazerooni
United States
University of Michigan Health System
Committee Member
Anna Kerpel-Fronius
Hungary
National Koranyi Institute of Pulmonology
Committee Member
David CL Lam
Hong Kong
The University of Hong Kong
Committee Member
Anant Mohan
India
All India Institute of Medical Sciences (AIIMS)
Committee Member
Ray Osarogiagbon
United States
Baptist Cancer Center
Committee Member
In Kyu Park
Korea
Seoul National University Hospital
Committee Member
Theresa Roelke
United States
Maine Medical Center Research Institute
Committee Member
John Ruckdeschel
United States
University of Mississippi Medical Center
Committee Member
Witold Rzyman
Poland
Medical University of Gdansk
Committee Member
Jacob Sands
United States
Dana-Farber Cancer Institute
Committee Member
Ricardo Santos
Brazil
Hospital Israelita Albert Einstein
Committee Member
Dorith Shaham
Israel
Hadassah- Hebrew University Medical Center
Committee Member
Junichi Soh
Japan
Kindai University
Committee Member
Martin Tammemägi
Canada
Cancer Care Ontario
Committee Member
Betty Tong
United States
Duke University
Committee Member
Natthaya Triphuridet
Thailand
Icahn School of Medicine at Mount Sinai
Committee Member
Luigi Ventura
United Kingdom
Sheffield Teaching Hospital NHS Foundation Trust
Committee Member
Lucia Viola
Colombia
Fundación Neumológica Colombiana
Committee Member
Chi-Fu Yang
United States
Harvard Medical School
Committee Member
Dawei Yang
China
zhongshan hospital Fudan University
Committee Member
David Yankelevitz
United States
Mount Sinai School of Medicine
Committee Member
Javier Zulueta
Spain
Clinica Universidad de Navarre
Committee Member

Related Resources

EU Call for Evidence Cover page
Recommendation
The International Association for the Study of Lung Cancer is an international network dedicated to...
Download(259.15 KB)
IASLC Position Statement
Lung cancer is a complicated disease with many causes. Among them are tobacco smoke, radon, and...
Download(109.17 KB)

Committee Nominations for the 2025-2027 term are now closed.

New Committee Nominations will take place again in 2027.